Optiray 350 mg I/ml (371 g/500 ml) sol. inj. i.artér. flac. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

optiray 350 mg i/ml (371 g/500 ml) sol. inj. i.artér. flac.

guerbet - ioversol 14,84 g/20 ml - solution injectable - 350 mg i/ml - ioversol 742 mg/ml - ioversol

OPTIRAY 320 Ioversol 84.75 g/125 mL injection Australia - engelsk - Department of Health (Therapeutic Goods Administration)

optiray 320 ioversol 84.75 g/125 ml injection

guerbet australia pty ltd - ioversol, quantity: 678 mg/ml (equivalent: iodine, qty 320 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; water for injections; hydrochloric acid; sodium hydroxide - optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used in intravenous excretory urography. optiray 320 is indicated in children (excluding neonates) for angiograpy, contrast enhanced computed tomographic imaging of the head and body, and intravenous excretory urography.

OPTIRAY 320 Ioversol 33.9 g/50 mL injection Australia - engelsk - Department of Health (Therapeutic Goods Administration)

optiray 320 ioversol 33.9 g/50 ml injection

guerbet australia pty ltd - ioversol, quantity: 678 mg/ml (equivalent: iodine, qty 320 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; water for injections; hydrochloric acid; sodium hydroxide - optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used in intravenous excretory urography. optiray 320 is indicated in children (excluding neonates) for angiograpy, contrast enhanced computed tomographic imaging of the head and body, and intravenous excretory urography.

OPTIRAY 240 Ioversol 63.63 g/125 mL injection syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

optiray 240 ioversol 63.63 g/125 ml injection syringe

guerbet australia pty ltd - ioversol, quantity: 509 mg/ml (equivalent: iodine, qty 240 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; water for injections; hydrochloric acid; sodium hydroxide - optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretory urography.

OPTIRAY 320 Ioversol 135.6g/200mL injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

optiray 320 ioversol 135.6g/200ml injection vial

guerbet australia pty ltd - ioversol, quantity: 678 mg/ml (equivalent: iodine, qty 320 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; water for injections; trometamol hydrochloride; sodium hydroxide - this product accepted for registration as 'currently supplied' at the time of commencement of the act. indications approved as specified in the letter of 19 april 1993 from dr h. arora are as follows: optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used in intravenous excretory urography. optiray 320 is indicated in children (excluding neonates) for angiography, contrast enhanced computed tomographic imaging of the head and body, and intravenous excretory urography.

OPTIRAY 320 Ioversol 101.7g/150mL injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

optiray 320 ioversol 101.7g/150ml injection vial

guerbet australia pty ltd - ioversol, quantity: 678 mg/ml (equivalent: iodine, qty 320 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; water for injections; trometamol hydrochloride; sodium hydroxide - this product accepted for registration as 'currently supplied' at the time of commencement of the act. indications approved as specified in the letter of 19 april 1993 from dr h. arora are as follows: optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used in intravenous excretory urography. optiray 320 is indicated in children (excluding neonates) for angiography, contrast enhanced computed tomographic imaging of the head and body, and intravenous excretory urography.

OPTIRAY 320 Ioversol 67.8g/100mL injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

optiray 320 ioversol 67.8g/100ml injection vial

guerbet australia pty ltd - ioversol, quantity: 678 mg/ml (equivalent: iodine, qty 320 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; water for injections; trometamol hydrochloride; sodium hydroxide - this product accepted for registration as 'currently supplied' at the time of commencement of the act. indications approved as specified in the letter of 19 april 1993 from dr h. arora are as follows: optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used in intravenous excretory urography. optiray 320 is indicated in children (excluding neonates) for angiography, contrast enhanced computed tomographic imaging of the head and body, and intravenous excretory urography.